EOPTOLINK(SZ:300502)2025-10-30 09:58Group 1: Company Performance Overview - The company maintained a good development trend in the first three quarters of 2025, achieving favorable operating results [3] - Q3 sales revenue slightly decreased compared to Q2 2025 due to changes in product shipment schedules [3] - The overall industry is expected to remain highly prosperous in Q4 2025 and 2026, with the company preparing to meet future order delivery needs [3] Group 2: Investor Inquiries and Responses - The company is closely monitoring actual order demand from clients, with a clear expectation of increased overall demand in the coming year [3] - The supply chain is operating normally, and the company has long-term relationships with suppliers to manage key raw materials effectively [3] - Capacity release from the Thailand factory will be a gradual process, with sufficient preparations made for future orders [3] Group 3: Product and Market Insights - The company anticipates a continuous increase in the shipment of 1.6T products from Q4 2025 to the following year [4] - The proportion of products with 800G and above is steadily increasing [5] - The company has already achieved bulk shipments of silicon photonic products, with strong technical and research capabilities in chip design [5] Group 4: Financial and R&D Considerations - R&D expenses decreased in Q3, but the company continues to invest heavily in R&D, adapting to market demands and technological advancements [5] - The company is actively managing inventory levels, with a reported increase of 700 million in inventory compared to the previous period [4] - The pricing for next year's modules is still under negotiation with clients, reflecting varying timelines for order confirmations [5]